Treatment of community-acquired pneumonia.

Abstract:

:Lower respiratory tract infections are the major cause of death due to infectious disease in the developed and developing world. Despite substantial progress in defining pathogens and in therapeutic options, there continues to be major controversies in the clinical management of these infections. This report reviews the guidelines for community-acquired pneumonia from the Infectious Diseases Society of America (IDSA), updated from the initial publication. Diagnosis should include a chest X-ray to differentiate acute bronchitis from pneumonia. The decision for hospitalization should be based on social factors and evaluation of severity of illness. Identification of an etiological agent for inpatients should include two pretreatment cultures, one pretreatment sputum specimen, with seriously ill patients requiring studies for Legionella spp. Recommendations for empiric treatment of outpatients are doxycycline, a macrolide or a fluoroquinolone. Recommendations for empiric treatment of hospitalized patients are a cephalosporin plus a macrolide, or a fluoroquinolone alone. Recommendations for ICU patients are a beta-lactam combined with either a macrolide or a fluoroquinolone. While concern has arisen about increasing resistance to fluoroquinolones, arguments in favor of these agents include the fact that they have good in vitro activity against nearly all treatable pathogens except some anaerobes. Clinical trials have shown equivalence or superiority compared to other standard agents. They are well tolerated, and can be administered intravenously or orally, once daily. A recent retrospective review has shown superior outcome with fluoroquinolone treatment compared to cephalosporins, including a 36% reduction in mortality.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Bartlett J

doi

10.1159/000048489

subject

Has Abstract

pub_date

2000-01-01 00:00:00

pages

24-31

eissn

0009-3157

issn

1421-9794

pii

48489

journal_volume

46 Suppl 1

pub_type

杂志文章,评审
  • Tapering and discontinuation of glucocorticoid prophylaxis during prolonged weekly to biweekly paclitaxel administration.

    abstract:BACKGROUND:Taxanes cause hypersensitivity reactions, averted by premedication with H1 blockers and high glucocorticoid (GC) doses. Prolonged weekly taxane administration may lead to GC toxicity. PURPOSE:To determine whether patients not hypersensitive to initial paclitaxel (PTX) infusion after high-dose GC premedicati...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000085618

    authors: Braverman AS,Rao S,Salvatti ME,Adamson B,McManus M,Pierre S

    更新日期:2005-05-01 00:00:00

  • Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015.

    abstract:BACKGROUND:This phase II study was conducted to evaluate the efficacy and safety of the chemotherapy combination of gemcitabine and vinorelbine in taxane-pretreated Japanese metastatic breast cancer patients. METHODS:In this multicenter, phase II, single-arm study, patients with recurrent or metastatic HER2-negative b...

    journal_title:Chemotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1159/000475879

    authors: Yamamura J,Masuda N,Yamamoto D,Tsuyuki S,Yamaguchi M,Tanaka S,Tsurutani J,Tokunaga S,Yoshidome K,Mizutani M,Aono T,Ooe A,Tanino H,Matsunami N,Yasojima H,Nakayama T,Nishida Y

    更新日期:2017-01-01 00:00:00

  • 5-Fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with advanced pancreatic cancer who have progressed on gemcitabine-based therapy.

    abstract:BACKGROUND/AIMS:There is no standard consensus on a strategy in the second-line setting for gemcitabine-refractory advanced pancreatic cancer. This study evaluated the activity and tolerability of oxaliplatin, irinotecan, 5-fluorouracil and leucovorin (FOLFIRINOX) as a second-line therapy in advanced pancreatic adenoca...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000356158

    authors: Lee MG,Lee SH,Lee SJ,Lee YS,Hwang JH,Ryu JK,Kim YT,Kim DU,Woo SM

    更新日期:2013-01-01 00:00:00

  • Studies on the antitumour effects of N-137.

    abstract::The antitumour properties of the drug N-137 were assessed in vivo in two murine T lymphoma models and two naturally metastatic hamster fibrosarcomas of Herpesvirus hominis aetiology. N-137 therapy caused a significant delay in the subcutaneous growth rate of both lymphomas (EL4 and TLX9) and in many cases completely p...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238091

    authors: Rees RC,Potter CW,Clegg A,Hall JM

    更新日期:1982-01-01 00:00:00

  • Post-antibiotic effects of cefdinir on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyrogenes.

    abstract::The post-antibiotic effects (PAEs) of a new cephalosporin, cefdinir, were determined against a range of organisms using a viable counting technique. Cefdinir exerted considerable PAEs against Staphylococcus aureus and Streptococcus pyogenes, but no overall post-antibiotic inhibition of growth was detected against Esch...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239198

    authors: Howard BM,Pinney RJ,Smith JT

    更新日期:1994-07-01 00:00:00

  • Tissue distribution of cefotetan in patients with Crohn's disease.

    abstract::Concentrations of cefotetan in the intestinal wall of patients with Crohn's disease were investigated with the method of tissue homogenates with the aim to evaluate the effects of inflammation on tissue distribution. Twenty-four patients who underwent surgery were treated with a 2-gram single dose of cefotetan intrave...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238871

    authors: Mazzei T,Tonelli F,Anastasi A,Ficari F,Novelli A,Periti P

    更新日期:1991-01-01 00:00:00

  • Pharmacokinetic studies of norfloxacin in laboratory animals.

    abstract::Pharmacokinetic studies were conducted with norfloxacin administered by the oral and subcutaneous routes to mice and rats, and by the oral route to rhesus monkeys. The compound was moderately well absorbed following oral dosing in these animal species. Serum levels in monkeys ranged from 1.0 to 2.35 micrograms/ml afte...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238283

    authors: Gilfillan EC,Pelak BA,Bland JA,Malatesta PF,Gadebusch HH

    更新日期:1984-01-01 00:00:00

  • Pharmacokinetics of oral co-trimazine and the penetration of its components sulfadiazine and trimethoprim into peripheral human lymph.

    abstract::Five healthy informed male volunteers received oral doses of 820 mg sulfadiazine (SDZ) plus 180 mg trimethoprim (TMP) (co-trimazine) every 24 h. Concentrations in serum, peripheral lymph from the leg and urine were determined after the first dose, and on the 4th day to reflect approximate steady-state conditions. TMP ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238418

    authors: Bergan T,Engeset A,Olszewski W

    更新日期:1986-01-01 00:00:00

  • Sensitivity of clinical isolates from German hospitals to amoxicillin/clavulanic acid (Augmentin) compared with other antibiotics.

    abstract::17,244 pathogens isolated from clinical specimens of 24 hospitals in the Moers area (North-Rhine Westphalia, FRG) were tested in regard to their susceptibility to Augmentin (amoxicillin and clavulanic acid). For this purpose, minimal inhibitory concentrations were determined by use of microbroth dilution technique. 80...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238588

    authors: Focht J,Klietmann W,Nösner K,Rolinson GN,Johnsen J

    更新日期:1988-01-01 00:00:00

  • Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.

    abstract::The in vitro antimicrobial activities of AM-1155, a new fluoroquinolone, tosufloxacin and fleroxacin were tested against 55 clinical isolates of Neisseria gonorrhoeae using the agar dilution method. In our previous study, all the strains had been examined for mutations in the region corresponding to the quinolone-resi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239573

    authors: Deguchi T,Yasuda M,Nakano M,Ozeki S,Kanematsu E,Fukuda H,Maeda S,Saito I,Kawada Y

    更新日期:1997-07-01 00:00:00

  • Killing of gram-negative bacteria by ciprofloxacin within both healthy human neutrophils and neutrophils with inactivated O2-dependent bactericidal mechanisms.

    abstract::The intraphagocytic killing of Escherichia coli, Serratia marcescens, Pseudomonas aeruginosa, and Salmonella typhi by ciprofloxacin (0.1, 1 and 5 microg/ml) within human neutrophils with intact and impaired (by phenylbutazone treatment) O2-dependent killing mechanisms was studied and compared with the extracellular ki...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007196

    authors: Cantón E,Peman J,Cabrera E,Velert M,Orero A,Pastor A,Gobernado M

    更新日期:1999-07-01 00:00:00

  • Undifferentiated carcinoma of the sinuses and cranial basis successfully treated with radiochemotherapy. A case report.

    abstract::The frustration and disappointment in managing advanced cancers of the nose and paranasal sinuses are well known. We report a case of a successful treatment of such a tumour in a 37-year-old soldier, using a combination of therapy including surgery, chemotherapy and radiation. Each mode of treatment is discussed. ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239218

    authors: Chandrasekaran S,Baba AA,Othman N,Jayakumar CR

    更新日期:1994-09-01 00:00:00

  • Bacteriological epidemiology and treatment of bacterial vaginosis.

    abstract::One hundred symptomatic women with clinical bacterial vaginosis (BV) were enrolled in this study. The bacteriological epidemiology of BV and efficacy of oral or vaginal administration of antimicrobial agents for treatment of BV were investigated. The epidemiology of BV was investigated before antimicrobial therapy. Fi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239425

    authors: Mikamo H,Kawazoe K,Izumi K,Ito K,Katoh N,Watanabe K,Ueno K,Tamaya T

    更新日期:1996-01-01 00:00:00

  • Therapeutic effects of cefozopran on polymicrobial infections associated with Enterococcus faecalis in a Rat pyometra model.

    abstract::Enterococcus faecalis plays an important role as a pathogen in polymicrobial infections. We evaluated the efficacy of cefozopran (CZOP) using polymicrobial pyometra rats. Rats were infected with a mixed intrauterine inoculation of E. faecalis plus either Bacteroides fragilis or Prevotella bivia (minimal inhibitory con...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007100

    authors: Mikamo H,Kawazoe K,Sato Y,Izumi K,Tamaya T

    更新日期:1998-03-01 00:00:00

  • Antibacterial effects of niridazole. I. Effect on infection of mice with Salmonella typhimurium.

    abstract::Niridazole was shown to be an effective chemotherapeutic agent for mice infected intravenously with a niridazole-sensitive strain of Salmonella typhimurium. Death rates as well as bacterial counts per spleen were reduced, even in compromised animals. Histologic examination of spleens proved the reduction of inflammato...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238069

    authors: Hof H,Müller KM,Heine WD

    更新日期:1982-01-01 00:00:00

  • Candida glabrata, Candida krusei, non-albicans Candida spp., and other fungal organisms in a sixty-bed national cancer center in 1989-1993: no association with the use of fluconazole.

    abstract::During the 5-year period 1989-1993, the incidence of Candida krusei, and other non-albicans Candida spp., was analyzed in a 60-bed cancer department. The frequency of C. krusei, before fluconazole was introduced into therapeutic protocols in 1990, was 16.5%, and after introduction of fluconazole into prophylaxis in ac...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239322

    authors: Kunová A,Trupl J,Spánik S,Drgona L,Sufliarsky J,Lacka J,Studená V,Hlavácová E,Studená M,Kukucková E

    更新日期:1995-01-01 00:00:00

  • Lipid peroxides in the polychemotherapy of cancer patients.

    abstract::There is evidence that a variety of anticancer drugs exert their cytotoxic activity by a free-radical-mediated mechanism. These drugs include anthracyclines such as adriamycin, daunorubicin, 4-epi-adriblastin as well as bleomycin, procarbazine, vincristin, cyclophosphamide, etoposide and mitomycin C. The aim of this s...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239163

    authors: Look MP,Musch E

    更新日期:1994-01-01 00:00:00

  • Dose linearity testing of intravenous ofloxacin, a novel gyrase inhibitor.

    abstract::After intravenous bolus injection of single doses of 25, 50, 75 and 100 mg of ofloxacin (HOE 280) to 34 healthy male volunteers, concentrations of unchanged drug were estimated at various times in serum and urine over 32 and 48 h. Ofloxacin concentrations were determined using high-pressure liquid chromatography (HPLC...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238567

    authors: Verho M,Korn A,Badian M,Malerczyk V,Waldhäusl W

    更新日期:1988-01-01 00:00:00

  • Influence of subinhibitory concentrations of protein-synthesis-inhibiting antibiotics on production and release of the pneumococcal virulence factor pneumolysin in vitro.

    abstract:OBJECTIVE:Pneumolysin is an important virulence factor of Streptococcus pneumoniae with cytotoxic and proinflammatory activities released during growth and autolysis. At concentrations above the minimal inhibitory concentration, the protein-synthesis-inhibiting antibiotics erythromycin, clindamycin and rifampicin inhib...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000107691

    authors: Spreer A,von Ruden C,Mitchell TJ,Eiffert H,Nau R

    更新日期:2007-01-01 00:00:00

  • Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer Xenografts.

    abstract:BACKGROUND/AIM:A phase 3 trial of S-1, leucovorin (LV), and oxaliplatin for treating gastric cancer is now underway. However, the antitumor efficacy of the combination has not yet been examined in an in vivo preclinical study. This study examined the antitumor efficacy of combination therapy consisting of S-1, LV, and ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000486029

    authors: Nagase H,Nakagawa F,Uchida J

    更新日期:2018-01-01 00:00:00

  • Pharmacokinetics of flomoxef in mucosal tissue of the middle ear and mastoid following intravenous administration in humans.

    abstract::The pharmacokinetics of flomoxef in serum and in the mucosal tissue of the middle ear and mastoid were studied in 9 patients undergoing tympanoplasties. All patients received 1 g of flomoxef intravenously. Flomoxef levels in serum and in mucosal tissue were determined by a bioassay method. The peak value of mean conce...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238766

    authors: Saito H,Kimura T,Takeda T,Kishimoto S,Oguma T,Shimamura K

    更新日期:1990-01-01 00:00:00

  • Antiandrogen and antineoplastic effects of a novel drug, CPC10997.

    abstract::CPC10997 was found to be effective in vitro as an antiandrogen without effects on either the estrogen or the progesterone receptors in carcinomas of the breast, ovary and prostate as well as in malignant melanomas. Using the clonogenic assay of Salmon et al. [Cancer Treat. Rep. 65: 1-12, 1981], CPC10997 was found to b...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238360

    authors: Ford LC,Kasha W,Chang NH,DeLange RJ

    更新日期:1985-01-01 00:00:00

  • Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma.

    abstract:BACKGROUNDS:The combination gemcitabine-oxaliplatin (GEMOX) is frequently used in patients with advanced biliary tract carcinoma (BTC). However, this is only based on phase II studies performed in selected patients.We assessed the efficacy and safety of the GEMOX regimen in non-selected patients with advanced BTC. MET...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000316848

    authors: Hollebecque A,Bouché O,Romano O,Scaglia E,Cattan S,Zerbib P,Heurgue A,Lagarde S,Mariette C,Triboulet JP,Pruvot FR,Hebbar M

    更新日期:2010-01-01 00:00:00

  • The value of tumor markers in evaluating chemotherapy response and prognosis in Chinese patients with advanced non-small cell lung cancer.

    abstract:OBJECTIVE:The aim of this study was to assess the value of tumor markers in monitoring chemotherapy response and predicting prognosis in patients with advanced non-small cell lung cancer (NSCLC). METHODS:We studied carcinoembryonic antigen (CEA), CYFRA21-1 and neuron-specific enolase (NSE) of 111 untreated patients wi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000317580

    authors: Jin B,Huang AM,Zhong RB,Han BH

    更新日期:2010-01-01 00:00:00

  • Once-daily ceftriaxone in the treatment of lower respiratory tract infections.

    abstract::We conducted a retrospective clinical evaluation to assess the efficacy of a 1-gram once-daily regimen of intravenously administered ceftriaxone in the treatment of a variety of bacterial infections. Of the 250 patients studied, 167 had infections of the lower respiratory tract, approximately 70% of which were diagnos...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238927

    authors: Brown R

    更新日期:1991-01-01 00:00:00

  • Pharmacokinetics of fosfomycin.

    abstract::Fosfomycin, an antibiotic discovered in Spain, has a unique chemical structure and pharmacologic features that are promising for clinical therapy. It is only partially absorbed orally, with relatively low blood levels. Intramuscularly, however, absorption is complete with peak blood levels 3-5 times as high as orally,...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000222040

    authors: Kirby WM

    更新日期:1977-01-01 00:00:00

  • Effect of in vitro acyclovir treatment on selected functions of blood-derived macrophages.

    abstract::The effect of acyclovir (ACV) treatment on selected functions of human blood-derived macrophages was examined. ACV was not cytotoxic when applied in a wide range of concentrations. Only minor effects on macrophage functions were observed when cells were treated with therapeutic concentrations of ACV:phagocytosis and t...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239126

    authors: Stenseth AM,Rollag H,Degré M

    更新日期:1993-05-01 00:00:00

  • Micro test for assaying sensitivity of Plasmodium vivax in vitro.

    abstract::A modified Rieckmann test was developed for assessing chloroquine sensitivity of Plasmodium vivax strains. This test envisages the evaluation of parasite growth with different concentrations of the drug and its comparison with controls, at the end of a 48-hour experimental period. Using this test, 16 strains were asse...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238664

    authors: Renapurkar DM,Pradhan VR,Sutar NK,Deshmukh RA,Pandit CH,Marathe SN

    更新日期:1989-01-01 00:00:00

  • Intra-aortal therapy with 5-fluorouracil- polyethylene glycol stealth liposomes: does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on ph value?. An animal study in VX-2 liver tumor-bearing rabbits.

    abstract:BACKGROUND:The application of liposome-encapsulated cytostatics results in higher concentrations in tumor tissue. This effect can be further increased by blood flow retardation with longer retention time in the tumor and by arterial administration realized in abdominal stop-flow therapy, a separate partial circulation ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000077805

    authors: Pohlen U,Binnenhei M,Reszka R,Buhr HJ,Berger G

    更新日期:2004-06-01 00:00:00

  • Inhibition of glycolysis and respiration of sarcoma-180 cells by echitamine chloride.

    abstract::Malignant tumors are known to exhibit high rates of glycolytic activity leading to high production of lactic acid. Hence, neoplastic cells have elevated activity of enzymes responsible for glycolysis. Echitamine chloride, an indole alkaloid extracted from the bark of Alstonia scholaris, has been reported to have a hig...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007115

    authors: Saraswathi V,Ramamoorthy N,Subramaniam S,Mathuram V,Gunasekaran P,Govindasamy S

    更新日期:1998-05-01 00:00:00